Cairo – Mubasher: Financial indicators for Alexandria Pharmaceuticals and Chemical Industries showed a 28.69% year-on-year increase in the company's net profit during the first quarter of the fiscal year 2026-2027.
The company explained in a disclosure to the Egyptian Exchange (EGX) today that it recorded a net profit of EGP 133.5 million during the period from July to the end of September 2026, compared to profits of EGP 103.74 million in the comparative period.
The company's sales declined during the three months to reach EGP 787.98 million, compared to EGP 799.9 million in the comparative period.
